The place of topical mucoactive drugs in the comprehensive treatment of acute paranasal sinusitis
Rhinology rapid development, the emergence of new and improvement of already known methods of diagnosis and treatment of paranasal sinuses (PNS) inflammatory diseases almost did not affect the prevalence growth rate of this pathology. Surgical interventions did not contribute to reducing the frequency of recurrence and chronicity of paranasal sinusitis, while the need for drug therapy is steadily increasing. The availability of the mucous membrane for drug exposure, its continuity in both the upper and lower respiratory tract, high reflexogenic response allow topically stimulating secretory activity, causing dehydration of all glandular components of the mucous membrane. The article presents the experience of using the drug, an extract of Cyclamen europaeum, in the treatment of acute rhinosinusitis. Clinical examples show the efficacy of its use both as monotherapy and in combination with systemic antibiotics. The significant drainage effect of the drug allows avoiding invasive methods of PNS lavage (puncture, intubation, etc.) in the complex therapy of this pathology and reducing the treatment duration by 3–4 days compared to the control group. Therefore, it can be recommended for wider use in the treatment of catarrhal processes and purulent inflammation of the nasal mucosa and PNS. KEYWORDS: acute rhinosinusitis, topical therapy, plant extracts, European cyclamen, efficacy, computed tomography, pneumatization, paranasal sinuses. FOR CITATION: Mashkova T.A., Maltsev A.B. The place of topical mucoactive drugs in the comprehensive treatment of acute paranasal sinusitis. Russian Medical Inquiry. 2021;5(7):508–512 (in Russ.). DOI: 10.32364/2587-6821-2021-5-7-508-512.